CLINDAMYCIN PHOSPHATE GEL USP, 1%

CLINDAMYCIN PHOSPHATE GEL USP, 1% was reported 3562 times

CLINDAMYCIN PHOSPHATE GEL USP, 1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYSTEMIC VIRAL INFECTION 3 0.2143
1 HIV ASSOCIATED NEPHROPATHY 3 0.0588
2 ANTIBIOTIC LEVEL BELOW THERAPEUTIC 5 0.0490
3 ANGIOMYOLIPOMA 8 0.0372
4 SINOBRONCHITIS 4 0.0268
5 OVERGROWTH BACTERIAL 5 0.0186
6 PRODUCT WITH QUALITY ISSUE ADMINISTERED 8 0.0179
7 ANORECTAL SWELLING 4 0.0175
8 GASTROINTESTINAL MUCOSA HYPERAEMIA 5 0.0169
9 VENOUS HAEMORRHAGE 5 0.0161
10 PROTEIN S DEFICIENCY 3 0.0152
11 SEVERE CUTANEOUS ADVERSE REACTION 3 0.0126
12 TUBO-OVARIAN ABSCESS 3 0.0123
13 CONGENITAL HYDROCEPHALUS 6 0.0118
14 TRACHEAL HAEMORRHAGE 4 0.0114
15 NASAL SEPTUM DISORDER 3 0.0113
16 COAGULATION FACTOR DECREASED 3 0.0110
17 MENINGOMYELOCELE 6 0.0100
18 BIOPSY LIVER 4 0.0097
19 VULVOVAGINAL INFLAMMATION 4 0.0087
20 TOXIC SHOCK SYNDROME 5 0.0079
21 POLYCYSTIC OVARIAN SYNDROME 3 0.0078
22 ENZYME LEVEL INCREASED 6 0.0071
23 HIDRADENITIS 64 0.0070
24 POUCHITIS 6 0.0070
25 CONGESTIVE HEPATOPATHY 3 0.0067
26 TRACHEITIS 5 0.0066
27 BLADDER DISCOMFORT 8 0.0064
28 ANAL INFLAMMATION 4 0.0063
29 ANAL ULCER 5 0.0061
30 FOREIGN BODY ASPIRATION 4 0.0055
31 HYPERTENSIVE URGENCY 3 0.0054
32 LYMPHOCYTE STIMULATION TEST POSITIVE 4 0.0050
33 MUSCLE ABSCESS 3 0.0048
34 ALLERGIC SINUSITIS 4 0.0047
35 OROPHARYNGEAL CANDIDIASIS 4 0.0044
36 PSEUDOMEMBRANOUS COLITIS 9 0.0040
37 PRODUCT CONTAINER SEAL ISSUE 7 0.0040
38 APPLICATION SITE DISCOMFORT 7 0.0039
39 CALCIUM DEFICIENCY 5 0.0039
40 PRODUCT PHYSICAL CONSISTENCY ISSUE 21 0.0038
41 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 29 0.0037
42 RESPIRATORY DISORDER NEONATAL 6 0.0037
43 RESORPTION BONE INCREASED 3 0.0037
44 SEBORRHOEIC DERMATITIS 6 0.0036
45 PUSTULE 8 0.0034
46 SKIN ODOUR ABNORMAL 13 0.0033
47 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
48 POST-ACUTE COVID-19 SYNDROME 4 0.0032
49 VENOUS INJURY 3 0.0032
50 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
51 MEGACOLON 5 0.0032
52 SOLAR LENTIGO 3 0.0032
53 VASCULAR PAIN 3 0.0031
54 ANGLE CLOSURE GLAUCOMA 8 0.0031
55 RETINAL DEGENERATION 4 0.0031
56 WOUND SECRETION 12 0.0031
57 MULTI-ORGAN DISORDER 6 0.0030
58 LEFT VENTRICULAR DYSFUNCTION 20 0.0030
59 BEZOAR 4 0.0029
60 DISCHARGE 4 0.0029
61 CUTANEOUS VASCULITIS 10 0.0027
62 AORTIC DILATATION 3 0.0027
63 IDIOPATHIC INTRACRANIAL HYPERTENSION 6 0.0027
64 INFECTED SKIN ULCER 5 0.0026
65 DERMATITIS ACNEIFORM 16 0.0026
66 CHEMICAL BURN 3 0.0026
67 FOLATE DEFICIENCY 3 0.0026
68 FEBRILE INFECTION 3 0.0025
69 PROCTITIS 7 0.0025
70 COLON CANCER METASTATIC 4 0.0025
71 TOXIC SKIN ERUPTION 25 0.0025
72 CLOSTRIDIUM COLITIS 3 0.0025
73 POOR QUALITY DRUG ADMINISTERED 16 0.0025
74 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
75 VITAMIN B12 DECREASED 7 0.0024
76 LIMB MASS 5 0.0023
77 WISDOM TEETH REMOVAL 3 0.0023
78 BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0023
79 MACULAR HOLE 3 0.0022
80 VULVOVAGINAL SWELLING 4 0.0022
81 MENINGITIS VIRAL 3 0.0022
82 VASCULAR PURPURA 3 0.0021
83 JOINT INSTABILITY 3 0.0021
84 INTERVERTEBRAL DISCITIS 4 0.0021
85 CATAPLEXY 3 0.0021
86 SELF ESTEEM DECREASED 5 0.0021
87 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
88 ORAL INFECTION 8 0.0020
89 TOXIC EPIDERMAL NECROLYSIS 31 0.0020
90 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
91 EPICONDYLITIS 3 0.0020
92 LOSS OF EMPLOYMENT 6 0.0020
93 DEPRESSIVE SYMPTOM 7 0.0020
94 PRODUCT CONTAMINATION PHYSICAL 5 0.0020
95 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
96 ROSACEA 9 0.0019
97 PRE-EXISTING CONDITION IMPROVED 12 0.0019
98 ORTHOPNOEA 6 0.0019
99 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
100 SUBCUTANEOUS ABSCESS 9 0.0019
101 SPUTUM INCREASED 4 0.0018
102 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0018
103 TOOTH INJURY 8 0.0018
104 CLOSTRIDIUM TEST POSITIVE 4 0.0018
105 SLEEP APNOEA SYNDROME 34 0.0018
106 HEPATORENAL SYNDROME 3 0.0018
107 CEREBELLAR INFARCTION 3 0.0018
108 TYMPANIC MEMBRANE PERFORATION 3 0.0018
109 BILIARY DYSKINESIA 3 0.0018
110 HAEMATOCRIT INCREASED 4 0.0018
111 DRUG ERUPTION 31 0.0017
112 IMMUNE THROMBOCYTOPENIA 8 0.0017
113 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
114 EYELID DISORDER 4 0.0017
115 PAPULE 12 0.0017
116 SKIN TIGHTNESS 8 0.0017
117 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
118 FEAR OF DISEASE 3 0.0017
119 MIXED LIVER INJURY 5 0.0017
120 VULVOVAGINAL PAIN 8 0.0017
121 LYMPHADENITIS 4 0.0017
122 ABSCESS LIMB 7 0.0016
123 VULVOVAGINAL BURNING SENSATION 10 0.0016
124 DYSCHEZIA 5 0.0016
125 ERYSIPELAS 8 0.0016
126 SCAR 27 0.0016
127 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0016
128 DIVERTICULUM 11 0.0015
129 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
130 SMALL INTESTINAL HAEMORRHAGE 3 0.0015
131 RASH MACULO-PAPULAR 33 0.0015
132 APPLICATION SITE DRYNESS 5 0.0015
133 DERMATITIS PSORIASIFORM 3 0.0015
134 WOUND COMPLICATION 5 0.0015
135 RASH MORBILLIFORM 4 0.0014
136 FOLLICULITIS 15 0.0014
137 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
138 DEVICE CONNECTION ISSUE 3 0.0014
139 SCLERODERMA 5 0.0014
140 PSYCHIATRIC SYMPTOM 10 0.0014
141 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
142 NEURODERMATITIS 5 0.0013
143 ADENOCARCINOMA 3 0.0013
144 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
145 AUTOIMMUNE THYROIDITIS 5 0.0013
146 PARANASAL SINUS DISCOMFORT 5 0.0013
147 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
148 EOSINOPHILIA 23 0.0013
149 BRUXISM 7 0.0013
150 METHAEMOGLOBINAEMIA 3 0.0013
151 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
152 SKIN PAPILLOMA 5 0.0012
153 VITAMIN B12 DEFICIENCY 5 0.0012
154 BRONCHITIS CHRONIC 3 0.0012
155 BACTERIAL SEPSIS 4 0.0012
156 ARTHRITIS BACTERIAL 5 0.0012
157 STAPHYLOCOCCAL SEPSIS 6 0.0012
158 SKIN REACTION 17 0.0012
159 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
160 CLOSTRIDIAL INFECTION 4 0.0012
161 HYPERPYREXIA 5 0.0012
162 SHOULDER OPERATION 5 0.0012
163 HYPERTRANSAMINASAEMIA 8 0.0011
164 MELANOCYTIC NAEVUS 5 0.0011
165 NECROTISING FASCIITIS 4 0.0011
166 SKIN LESION 31 0.0011
167 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
168 SHOULDER ARTHROPLASTY 3 0.0011
169 APPLICATION SITE PAIN 24 0.0011
170 SEBORRHOEA 4 0.0011
171 EOSINOPHIL COUNT INCREASED 9 0.0011
172 ANAL HAEMORRHAGE 3 0.0011
173 FLANK PAIN 10 0.0011
174 PRODUCT PACKAGING ISSUE 10 0.0011
175 PRODUCT ODOUR ABNORMAL 11 0.0010
176 CYST 13 0.0010
177 DEVICE PHYSICAL PROPERTY ISSUE 8 0.0010
178 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 57 0.0010
179 NECK INJURY 3 0.0010
180 PHARYNGEAL SWELLING 10 0.0010
181 PURPURA 9 0.0010
182 ATYPICAL PNEUMONIA 3 0.0010
183 FUNGAL SKIN INFECTION 4 0.0010
184 ENURESIS 4 0.0010
185 ENDOCARDITIS 5 0.0010
186 LARYNGEAL OEDEMA 6 0.0010
187 HYPERURICAEMIA 4 0.0010
188 SCREAMING 6 0.0009
189 DRUG SPECIFIC ANTIBODY PRESENT 6 0.0009
190 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
191 OESOPHAGITIS 10 0.0009
192 DEAFNESS NEUROSENSORY 3 0.0009
193 ONYCHOMYCOSIS 4 0.0009
194 TOOTH FRACTURE 10 0.0009
195 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
196 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
197 PLANTAR FASCIITIS 3 0.0009
198 BREAST MASS 6 0.0009
199 METASTASES TO SPINE 3 0.0009
200 SUSPECTED OFF LABEL USE 4 0.0009
201 PERIORBITAL SWELLING 5 0.0009
202 FURUNCLE 7 0.0009
203 PREMATURE DELIVERY 14 0.0009
204 MICTURITION DISORDER 3 0.0009
205 HANGOVER 3 0.0009
206 RENAL FAILURE ACUTE 36 0.0008
207 THERMAL BURN 6 0.0008
208 COLITIS MICROSCOPIC 4 0.0008
209 BURSITIS 10 0.0008
210 MAJOR DEPRESSION 6 0.0008
211 THROMBOCYTOSIS 3 0.0008
212 PRODUCT CONTAINER ISSUE 7 0.0008
213 NASAL POLYPS 4 0.0008
214 APPLICATION SITE BURN 4 0.0008
215 WOUND HAEMORRHAGE 3 0.0008
216 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
217 ABDOMINAL TENDERNESS 4 0.0008
218 HEPATIC STEATOSIS 15 0.0008
219 SKIN INFECTION 9 0.0008
220 VEIN DISORDER 4 0.0008
221 PROTEIN TOTAL DECREASED 3 0.0008
222 SNORING 3 0.0008
223 CHOLESTASIS 15 0.0008
224 SKIN ULCER 20 0.0008
225 SPINAL CORD COMPRESSION 3 0.0008
226 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
227 CHEILITIS 4 0.0007
228 DECUBITUS ULCER 6 0.0007
229 GINGIVAL BLEEDING 10 0.0007
230 ACUTE HEPATIC FAILURE 10 0.0007
231 ATELECTASIS 7 0.0007
232 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
233 FOOT DEFORMITY 8 0.0007
234 STEVENS-JOHNSON SYNDROME 16 0.0007
235 ATRIAL SEPTAL DEFECT 6 0.0007
236 PRODUCT LEAKAGE 4 0.0007
237 FISTULA 8 0.0007
238 BODY TEMPERATURE DECREASED 7 0.0007
239 LOCALISED INFECTION 17 0.0007
240 DERMATITIS CONTACT 8 0.0007
241 CHOLECYSTECTOMY 8 0.0007
242 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
243 SKIN SWELLING 6 0.0007
244 HYPERVENTILATION 4 0.0007
245 ABSCESS 11 0.0007
246 ECZEMA 36 0.0007
247 DIVERTICULUM INTESTINAL 3 0.0007
248 ACNE 52 0.0007
249 NAIL DISORDER 6 0.0007
250 FOOT FRACTURE 13 0.0007
251 PARONYCHIA 3 0.0007
252 PETECHIAE 7 0.0007
253 HAEMOLYTIC ANAEMIA 6 0.0007
254 PROTHROMBIN TIME PROLONGED 4 0.0007
255 IRON DEFICIENCY 3 0.0007
256 SINUS CONGESTION 9 0.0007
257 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
258 HEPATITIS CHOLESTATIC 4 0.0007
259 ACNE CYSTIC 2 0.0007
260 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
261 PATHOGEN RESISTANCE 6 0.0007
262 HAEMODYNAMIC INSTABILITY 5 0.0007
263 RETINAL DETACHMENT 6 0.0007
264 ANAPHYLACTIC REACTION 36 0.0007
265 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
266 FOOD ALLERGY 5 0.0006
267 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
268 RENAL FUNCTION TEST ABNORMAL 3 0.0006
269 APHTHOUS ULCER 5 0.0006
270 BIPOLAR DISORDER 7 0.0006
271 THERAPY PARTIAL RESPONDER 10 0.0006
272 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
273 SKIN ABRASION 3 0.0006
274 OBESITY 10 0.0006
275 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
276 CELLULITIS 31 0.0006
277 HORMONE LEVEL ABNORMAL 3 0.0006
278 ANHEDONIA 16 0.0006
279 HAIR DISORDER 5 0.0006
280 PROTEIN URINE PRESENT 3 0.0006
281 DERMATITIS EXFOLIATIVE 3 0.0006
282 BONE LOSS 9 0.0006
283 CHOLECYSTITIS CHRONIC 4 0.0006
284 HAEMODIALYSIS 5 0.0006
285 BACTERAEMIA 7 0.0006
286 RASH 257 0.0006
287 TOOTH ABSCESS 6 0.0006
288 LIMB INJURY 16 0.0006
289 BLISTER 33 0.0006
290 IMPAIRED GASTRIC EMPTYING 8 0.0006
291 PHLEBITIS 3 0.0006
292 SKIN HYPERPIGMENTATION 5 0.0006
293 ONYCHOCLASIS 4 0.0006
294 RASH PAPULAR 13 0.0006
295 BLOOD MAGNESIUM DECREASED 5 0.0006
296 HAIR GROWTH ABNORMAL 4 0.0006
297 DERMATITIS 12 0.0006
298 FUNGAL INFECTION 19 0.0006
299 SKIN DISORDER 19 0.0006
300 JOINT DISLOCATION 6 0.0006
301 HEPATOCELLULAR INJURY 8 0.0006
302 APPLICATION SITE IRRITATION 7 0.0006
303 BRONCHOSPASM 8 0.0006
304 FOOD POISONING 3 0.0006
305 FACIAL PAIN 5 0.0006
306 PARALYSIS 8 0.0006
307 ANAL INCONTINENCE 5 0.0006
308 ERYTHEMA OF EYELID 3 0.0006
309 TONGUE DISORDER 4 0.0006
310 RASH PUSTULAR 4 0.0005
311 DRUG RESISTANCE 14 0.0005
312 RASH MACULAR 19 0.0005
313 INCREASED TENDENCY TO BRUISE 5 0.0005
314 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
315 BURNING SENSATION 38 0.0005
316 COAGULOPATHY 9 0.0005
317 ARTHROPOD BITE 4 0.0005
318 SKIN HAEMORRHAGE 8 0.0005
319 NECROSIS 3 0.0005
320 SUNBURN 4 0.0005
321 BACTERIAL INFECTION 10 0.0005
322 FACE OEDEMA 9 0.0005
323 LACERATION 5 0.0005
324 PAROSMIA 4 0.0005
325 SEPTIC SHOCK 23 0.0005
326 TENDON PAIN 4 0.0005
327 SCAB 6 0.0005
328 MYOCARDITIS 6 0.0005
329 POST PROCEDURAL COMPLICATION 10 0.0005
330 ANGIOEDEMA 23 0.0005
331 ENTEROCOLITIS 3 0.0005
332 THROAT TIGHTNESS 14 0.0005
333 RALES 3 0.0005
334 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
335 POST PROCEDURAL HAEMORRHAGE 6 0.0005
336 VASCULITIS 6 0.0005
337 PRODUCT LABEL CONFUSION 3 0.0005
338 AUTOIMMUNE DISORDER 5 0.0005
339 HAEMORRHOIDS 10 0.0005
340 INFLAMMATORY BOWEL DISEASE 5 0.0005
341 POOR QUALITY SLEEP 11 0.0005
342 OSTEOPOROSIS 21 0.0005
343 LIP SWELLING 17 0.0005
344 DRUG-INDUCED LIVER INJURY 16 0.0005
345 TORSADE DE POINTES 4 0.0005
346 VITREOUS FLOATERS 5 0.0005
347 LYMPHADENOPATHY 18 0.0005
348 RESPIRATORY DISTRESS 14 0.0005
349 SINUS DISORDER 10 0.0005
350 HAEMATOCRIT DECREASED 10 0.0005
351 RENAL CYST 4 0.0005
352 ODYNOPHAGIA 3 0.0005
353 RASH ERYTHEMATOUS 24 0.0005
354 HEARING IMPAIRED 3 0.0005
355 LEUKOCYTOSIS 9 0.0005
356 SEASONAL ALLERGY 7 0.0005
357 TASTE DISORDER 10 0.0005
358 ERYTHEMA 101 0.0005
359 INTENTIONAL DOSE OMISSION 14 0.0005
360 RESPIRATORY DEPRESSION 6 0.0005
361 ABNORMAL FAECES 4 0.0005
362 HICCUPS 4 0.0005
363 DRY SKIN 65 0.0005
364 STAPHYLOCOCCAL INFECTION 16 0.0005
365 AGRANULOCYTOSIS 9 0.0005
366 NASAL DRYNESS 3 0.0005
367 PALLOR 13 0.0005
368 DERMATITIS ALLERGIC 6 0.0005
369 CANDIDA INFECTION 8 0.0005
370 HEPATIC CYTOLYSIS 6 0.0005
371 C-REACTIVE PROTEIN INCREASED 17 0.0005
372 PROCTALGIA 3 0.0005
373 WOUND 13 0.0005
374 PSYCHOLOGICAL TRAUMA 4 0.0005
375 MULTI-ORGAN FAILURE 8 0.0005
376 PYELONEPHRITIS 4 0.0005
377 SOMNAMBULISM 3 0.0005
378 DRUG INTOLERANCE 44 0.0005
379 IMMUNE SYSTEM DISORDER 6 0.0005
380 ANKYLOSING SPONDYLITIS 6 0.0005
381 DERMATITIS ATOPIC 24 0.0005
382 TOOTH INFECTION 6 0.0005
383 GASTROINTESTINAL PAIN 5 0.0005
384 ABDOMINAL ABSCESS 2 0.0005
385 DENTAL CARIES 5 0.0005
386 RESPIRATORY RATE INCREASED 4 0.0005
387 QUALITY OF LIFE DECREASED 6 0.0004
388 MALNUTRITION 5 0.0004
389 INFLAMMATION 23 0.0004
390 COLITIS ISCHAEMIC 3 0.0004
391 CONDITION AGGRAVATED 135 0.0004
392 OROPHARYNGEAL DISCOMFORT 4 0.0004
393 PNEUMOTHORAX 7 0.0004
394 ULCER 7 0.0004
395 RESTLESS LEGS SYNDROME 8 0.0004
396 PRODUCT USE IN UNAPPROVED INDICATION 109 0.0004
397 SKIN EXFOLIATION 37 0.0004
398 PRURITUS 168 0.0004
399 TINNITUS 20 0.0004
400 SHOCK 10 0.0004
401 PULMONARY EMBOLISM 41 0.0004
402 CONJUNCTIVITIS 8 0.0004
403 EYELID OEDEMA 5 0.0004
404 SWELLING FACE 28 0.0004
405 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
406 DEFAECATION URGENCY 3 0.0004
407 SUICIDAL IDEATION 39 0.0004
408 RASH GENERALISED 11 0.0004
409 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
410 SPUTUM DISCOLOURED 4 0.0004
411 DEAFNESS 11 0.0004
412 APPLICATION SITE ERYTHEMA 11 0.0004
413 URTICARIA 70 0.0004
414 FAECES DISCOLOURED 9 0.0004
415 SKIN IRRITATION 19 0.0004
416 DERMATITIS BULLOUS 3 0.0004
417 SCHIZOPHRENIA 5 0.0004
418 RESPIRATORY FAILURE 30 0.0004
419 TREATMENT FAILURE 34 0.0004
420 SURGERY 24 0.0004
421 SKIN FISSURES 8 0.0004
422 MELAENA 9 0.0004
423 GASTRIC DISORDER 14 0.0004
424 ENCEPHALOPATHY 10 0.0004
425 LIVER DISORDER 18 0.0004
426 TOOTH DISORDER 9 0.0004
427 LIGAMENT SPRAIN 4 0.0004
428 PHARYNGITIS 5 0.0004
429 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
430 HYPOTONIA 4 0.0004
431 POOR QUALITY DEVICE USED 4 0.0004
432 HAEMATOCHEZIA 22 0.0004
433 ACUTE KIDNEY INJURY 61 0.0004
434 STOMATITIS 24 0.0004
435 VAGINAL DISCHARGE 4 0.0004
436 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
437 TROPONIN INCREASED 3 0.0004
438 AORTIC ANEURYSM 3 0.0004
439 BONE MARROW FAILURE 8 0.0004
440 DIABETES MELLITUS 30 0.0004
441 MOTOR DYSFUNCTION 4 0.0004
442 GALLBLADDER DISORDER 7 0.0004
443 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
444 RENAL FAILURE CHRONIC 3 0.0004
445 ANAPHYLACTIC SHOCK 10 0.0004
446 OSTEOMYELITIS 7 0.0004
447 LUNG INFECTION 6 0.0004
448 HYPOALBUMINAEMIA 3 0.0004
449 APNOEA 3 0.0004
450 RED BLOOD CELL COUNT DECREASED 11 0.0004
451 SWOLLEN TONGUE 12 0.0004
452 TENDERNESS 4 0.0004
453 PULMONARY HAEMORRHAGE 3 0.0004
454 NODULE 5 0.0004
455 MUCOSAL INFLAMMATION 10 0.0004
456 ORAL CANDIDIASIS 5 0.0004
457 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
458 NASAL DISCOMFORT 3 0.0004
459 PLEURAL EFFUSION 23 0.0004
460 GINGIVAL PAIN 3 0.0004
461 ATRIAL FLUTTER 3 0.0004
462 BONE PAIN 22 0.0004
463 HEPATIC FUNCTION ABNORMAL 14 0.0004
464 SENSORY LOSS 3 0.0004
465 BLOOD SODIUM DECREASED 7 0.0004
466 HYPOXIA 13 0.0004
467 RASH PRURITIC 20 0.0004
468 POST PROCEDURAL INFECTION 3 0.0004
469 SHOCK HAEMORRHAGIC 3 0.0004
470 LIVER INJURY 9 0.0004
471 BLOOD POTASSIUM DECREASED 11 0.0004
472 PREMATURE BABY 11 0.0004
473 HYPERAESTHESIA 3 0.0004
474 RENAL DISORDER 17 0.0004
475 ESCHERICHIA INFECTION 3 0.0004
476 SPINAL COMPRESSION FRACTURE 3 0.0004
477 EMBOLISM 3 0.0004
478 NERVE INJURY 4 0.0004
479 MATERNAL EXPOSURE DURING PREGNANCY 32 0.0004
480 URINARY TRACT INFECTION 61 0.0004
481 EYE PRURITUS 12 0.0004
482 SENSATION OF FOREIGN BODY 3 0.0004
483 SKIN PLAQUE 3 0.0004
484 EYE INFECTION 4 0.0004
485 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
486 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
487 INTERSTITIAL LUNG DISEASE 17 0.0004
488 VITAMIN D DECREASED 3 0.0004
489 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
490 HYPERSENSITIVITY 65 0.0003
491 ILLNESS 36 0.0003
492 ANURIA 3 0.0003
493 PARANOIA 6 0.0003
494 HYPOKALAEMIA 16 0.0003
495 HYSTERECTOMY 3 0.0003
496 PERICARDIAL EFFUSION 8 0.0003
497 RENAL IMPAIRMENT 29 0.0003
498 HYPERTENSION 73 0.0003
499 GASTRITIS 9 0.0003
500 METASTASES TO LIVER 6 0.0003
501 TUMOUR LYSIS SYNDROME 3 0.0003
502 ASCITES 10 0.0003
503 IMMUNOSUPPRESSION 3 0.0003
504 LEUKOPENIA 17 0.0003
505 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
506 INFECTION 49 0.0003
507 PULMONARY HYPERTENSION 7 0.0003
508 PULMONARY MASS 5 0.0003
509 MYOCLONUS 4 0.0003
510 JAUNDICE 9 0.0003
511 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
512 FREQUENT BOWEL MOVEMENTS 9 0.0003
513 TOOTHACHE 6 0.0003
514 LACRIMATION INCREASED 10 0.0003
515 PNEUMONITIS 9 0.0003
516 ARTHRITIS 26 0.0003
517 LIP DRY 3 0.0003
518 URINARY RETENTION 11 0.0003
519 PSORIASIS 43 0.0003
520 NEPHROLITHIASIS 15 0.0003
521 INSURANCE ISSUE 5 0.0003
522 IRRITABLE BOWEL SYNDROME 7 0.0003
523 RECTAL HAEMORRHAGE 14 0.0003
524 MUSCLE SPASTICITY 4 0.0003
525 UROSEPSIS 3 0.0003
526 NERVE COMPRESSION 3 0.0003
527 SPINAL OPERATION 4 0.0003
528 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
529 GENERALISED OEDEMA 4 0.0003
530 MUSCULOSKELETAL CHEST PAIN 5 0.0003
531 EYE SWELLING 12 0.0003
532 ERYTHEMA MULTIFORME 3 0.0003
533 HEPATIC ENCEPHALOPATHY 3 0.0003
534 APPENDICITIS 3 0.0003
535 SKIN BURNING SENSATION 23 0.0003
536 DIARRHOEA HAEMORRHAGIC 3 0.0003
537 DRY EYE 16 0.0003
538 PNEUMONIA ASPIRATION 8 0.0003
539 INJECTION SITE DISCOLOURATION 4 0.0003
540 BRAIN FOG 5 0.0003
541 PHOTOPHOBIA 6 0.0003
542 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
543 HALLUCINATION, AUDITORY 5 0.0003
544 HEPATOTOXICITY 7 0.0003
545 PRODUCTIVE COUGH 15 0.0003
546 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
547 METABOLIC ACIDOSIS 10 0.0003
548 HEPATITIS 8 0.0003
549 PYREXIA 108 0.0003
550 MYDRIASIS 4 0.0003
551 VERTIGO 19 0.0003
552 RHABDOMYOLYSIS 13 0.0003
553 SENSORY DISTURBANCE 5 0.0003
554 PRODUCT QUALITY ISSUE 42 0.0003
555 DYSPHONIA 18 0.0003
556 BACK DISORDER 5 0.0003
557 ORAL HERPES 6 0.0003
558 COELIAC DISEASE 3 0.0003
559 SKIN DISCOLOURATION 14 0.0003
560 UNEVALUABLE EVENT 23 0.0003
561 HOSPICE CARE 3 0.0003
562 VENTRICULAR TACHYCARDIA 5 0.0003
563 ABDOMINAL PAIN UPPER 62 0.0003
564 EAR INFECTION 8 0.0003
565 VIRAL INFECTION 10 0.0003
566 FLATULENCE 17 0.0003
567 EYE HAEMORRHAGE 4 0.0003
568 DEPRESSION 68 0.0003
569 FULL BLOOD COUNT DECREASED 6 0.0003
570 EMPHYSEMA 3 0.0003
571 SEPSIS 33 0.0003
572 EYELID PTOSIS 3 0.0003
573 DIARRHOEA 190 0.0003
574 EPISTAXIS 22 0.0003
575 BODY TEMPERATURE INCREASED 6 0.0003
576 INITIAL INSOMNIA 3 0.0003
577 MUSCULOSKELETAL DISCOMFORT 5 0.0003
578 COLITIS 11 0.0003
579 HYPERBILIRUBINAEMIA 3 0.0003
580 VENTRICULAR EXTRASYSTOLES 3 0.0003
581 ORAL DISCOMFORT 4 0.0003
582 HYPOMAGNESAEMIA 4 0.0003
583 WEIGHT FLUCTUATION 3 0.0003
584 CEREBRAL INFARCTION 7 0.0003
585 PANCYTOPENIA 16 0.0003
586 NECK PAIN 16 0.0003
587 MASS 4 0.0003
588 HYPERKALAEMIA 10 0.0003
589 SCRATCH 3 0.0003
590 BLINDNESS UNILATERAL 4 0.0003
591 SUDDEN DEATH 3 0.0003
592 CHEST DISCOMFORT 29 0.0003
593 DRUG INEFFECTIVE 373 0.0003
594 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
595 ANXIETY 80 0.0003
596 BODY HEIGHT DECREASED 3 0.0003
597 HYPERSOMNIA 8 0.0003
598 CARDIOGENIC SHOCK 4 0.0003
599 RHINORRHOEA 18 0.0003
600 MOBILITY DECREASED 20 0.0003
601 IMPAIRED QUALITY OF LIFE 4 0.0003
602 LETHARGY 16 0.0003
603 DECREASED ACTIVITY 3 0.0003
604 DEHYDRATION 37 0.0003
605 PHARYNGITIS STREPTOCOCCAL 3 0.0003
606 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
607 SKIN LACERATION 3 0.0003
608 CARDIOVASCULAR DISORDER 7 0.0003
609 PELVIC PAIN 5 0.0003
610 FLUID OVERLOAD 4 0.0003
611 BLOOD PRESSURE INCREASED 42 0.0003
612 WOUND INFECTION 3 0.0003
613 OCULAR HYPERAEMIA 13 0.0003
614 COUGH 76 0.0003
615 TACHYCARDIA 24 0.0003
616 NEUTROPHIL COUNT DECREASED 11 0.0003
617 TRANSAMINASES INCREASED 6 0.0003
618 HYPERTENSIVE CRISIS 3 0.0003
619 RESPIRATORY TRACT INFECTION 7 0.0003
620 THROAT IRRITATION 12 0.0003
621 SWELLING 25 0.0003
622 EYE PAIN 15 0.0003
623 STATUS EPILEPTICUS 3 0.0003
624 ECONOMIC PROBLEM 4 0.0003
625 BLOOD COUNT ABNORMAL 4 0.0003
626 PRODUCT AVAILABILITY ISSUE 6 0.0003
627 PROTEINURIA 5 0.0003
628 PAIN 161 0.0003
629 ACIDOSIS 2 0.0003
630 DEEP VEIN THROMBOSIS 17 0.0003
631 BLOOD CREATININE INCREASED 17 0.0003
632 MUSCLE TWITCHING 6 0.0003
633 PHARYNGEAL OEDEMA 4 0.0003
634 OFF LABEL USE 227 0.0003
635 DRY MOUTH 21 0.0003
636 MADAROSIS 3 0.0003
637 FEMUR FRACTURE 8 0.0003
638 ABDOMINAL DISCOMFORT 43 0.0003
639 SPLENOMEGALY 3 0.0003
640 INJURY 18 0.0003
641 NASAL CONGESTION 15 0.0003
642 CYANOSIS 4 0.0003
643 DYSPEPSIA 25 0.0003
644 VAGINAL HAEMORRHAGE 11 0.0003
645 DYSPHAGIA 24 0.0003
646 BLOOD IRON DECREASED 3 0.0003
647 DIVERTICULITIS 7 0.0003
648 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
649 UPPER LIMB FRACTURE 5 0.0003
650 HAEMOPTYSIS 7 0.0003
651 THROMBOCYTOPENIA 28 0.0003
652 CARDIAC FAILURE CONGESTIVE 20 0.0002
653 HIP FRACTURE 8 0.0002
654 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
655 NIGHT SWEATS 8 0.0002
656 PRODUCT DOSE OMISSION ISSUE 73 0.0002
657 ASTHMA 28 0.0002
658 CHILLS 29 0.0002
659 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
660 FIBROMYALGIA 6 0.0002
661 FEEDING DISORDER 5 0.0002
662 PSORIATIC ARTHROPATHY 10 0.0002
663 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
664 IMPAIRED HEALING 8 0.0002
665 HAEMOGLOBIN DECREASED 25 0.0002
666 INJECTION SITE EXTRAVASATION 3 0.0002
667 HEART RATE INCREASED 24 0.0002
668 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
669 ILEUS 3 0.0002
670 INFUSION RELATED REACTION 16 0.0002
671 HAIR COLOUR CHANGES 3 0.0002
672 PNEUMONIA 78 0.0002
673 EXPIRED PRODUCT ADMINISTERED 8 0.0002
674 BRAIN OEDEMA 3 0.0002
675 MOUTH ULCERATION 5 0.0002
676 MUSCLE ATROPHY 3 0.0002
677 NAUSEA 186 0.0002
678 EATING DISORDER 5 0.0002
679 HEPATIC ENZYME INCREASED 16 0.0002
680 GASTROINTESTINAL DISORDER 21 0.0002
681 IMPAIRED WORK ABILITY 5 0.0002
682 FEELING ABNORMAL 56 0.0002
683 ROTATOR CUFF SYNDROME 3 0.0002
684 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
685 INFUSION SITE PAIN 3 0.0002
686 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
687 HEPATIC FAILURE 7 0.0002
688 DISEASE RECURRENCE 11 0.0002
689 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
690 DIPLOPIA 6 0.0002
691 OEDEMA PERIPHERAL 28 0.0002
692 ORTHOSTATIC HYPOTENSION 4 0.0002
693 DRUG ADMINISTRATION ERROR 7 0.0002
694 DRUG INTERACTION 36 0.0002
695 FEBRILE NEUTROPENIA 15 0.0002
696 HEAD DISCOMFORT 4 0.0002
697 WEIGHT DECREASED 63 0.0002
698 HAIR TEXTURE ABNORMAL 3 0.0002
699 ALOPECIA 44 0.0002
700 THIRST 4 0.0002
701 CEREBRAL HAEMORRHAGE 8 0.0002
702 PULMONARY OEDEMA 10 0.0002
703 SNEEZING 5 0.0002
704 GASTROENTERITIS VIRAL 4 0.0002
705 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
706 TACHYPNOEA 3 0.0002
707 BONE DISORDER 4 0.0002
708 CORONARY ARTERY OCCLUSION 3 0.0002
709 RESTLESSNESS 8 0.0002
710 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
711 APPLICATION SITE RASH 3 0.0002
712 FATIGUE 169 0.0002
713 PLATELET COUNT DECREASED 23 0.0002
714 CONSTIPATION 47 0.0002
715 JOINT SWELLING 26 0.0002
716 VOMITING 100 0.0002
717 SLEEP DISORDER 15 0.0002
718 MALAISE 93 0.0002
719 DISEASE PROGRESSION 25 0.0002
720 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
721 CHRONIC KIDNEY DISEASE 16 0.0002
722 GASTRIC ULCER 4 0.0002
723 MUSCULOSKELETAL DISORDER 4 0.0002
724 HERPES ZOSTER 12 0.0002
725 PULMONARY FIBROSIS 4 0.0002
726 DRUG PRESCRIBING ERROR 4 0.0002
727 PARAESTHESIA ORAL 3 0.0002
728 GLAUCOMA 4 0.0002
729 ANOSMIA 3 0.0002
730 HYPERTHYROIDISM 3 0.0002
731 HERNIA 4 0.0002
732 MENTAL IMPAIRMENT 5 0.0002
733 CARDIAC ARREST 17 0.0002
734 OROPHARYNGEAL PAIN 19 0.0002
735 CHOKING 4 0.0002
736 KIDNEY INFECTION 4 0.0002
737 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
738 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
739 DECREASED APPETITE 47 0.0002
740 DYSPNOEA 114 0.0002
741 COLON CANCER 3 0.0002
742 PREGNANCY 4 0.0002
743 IRRITABILITY 12 0.0002
744 HEART RATE DECREASED 7 0.0002
745 ANAEMIA 38 0.0002
746 PRODUCT PHYSICAL ISSUE 4 0.0002
747 PRODUCT ADMINISTRATION ERROR 4 0.0002
748 PRODUCT USE ISSUE 37 0.0002
749 BLINDNESS 8 0.0002
750 RENAL FAILURE 26 0.0002
751 SINUSITIS 20 0.0002
752 LOSS OF CONSCIOUSNESS 25 0.0002
753 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
754 RIB FRACTURE 4 0.0002
755 ANKLE FRACTURE 3 0.0002
756 DELUSION 3 0.0002
757 ACUTE MYELOID LEUKAEMIA 3 0.0002
758 DYSURIA 7 0.0002
759 ARTHRALGIA 79 0.0002
760 KNEE ARTHROPLASTY 4 0.0002
761 MIGRAINE 18 0.0002
762 CYSTITIS 6 0.0002
763 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
764 JOINT INJURY 4 0.0002
765 CARDIAC FAILURE 15 0.0002
766 HOT FLUSH 14 0.0002
767 PAIN OF SKIN 5 0.0002
768 WHEEZING 11 0.0002
769 MUSCLE TIGHTNESS 3 0.0002
770 BLOOD BILIRUBIN INCREASED 5 0.0002
771 PRURITUS GENERALISED 4 0.0002
772 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
773 PRODUCT PRESCRIBING ISSUE 4 0.0002
774 METASTASES TO BONE 3 0.0002
775 PHOTOSENSITIVITY REACTION 3 0.0002
776 THERAPEUTIC RESPONSE DECREASED 11 0.0002
777 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
778 HEADACHE 113 0.0002
779 FEELING COLD 5 0.0002
780 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
781 FEELING HOT 11 0.0002
782 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
783 CONTUSION 17 0.0002
784 PAIN IN EXTREMITY 52 0.0002
785 APPLICATION SITE PRURITUS 4 0.0002
786 CIRCULATORY COLLAPSE 3 0.0002
787 BRONCHITIS 13 0.0002
788 PERIPHERAL SWELLING 27 0.0002
789 HAEMATURIA 6 0.0002
790 ABORTION SPONTANEOUS 7 0.0002
791 ATRIAL FIBRILLATION 17 0.0002
792 EYE IRRITATION 10 0.0002
793 EMOTIONAL DISTRESS 21 0.0002
794 DELIRIUM 6 0.0002
795 CHEST PAIN 32 0.0002
796 DIZZINESS 86 0.0002
797 DYSKINESIA 7 0.0002
798 PALPITATIONS 20 0.0002
799 COLD SWEAT 3 0.0002
800 LABORATORY TEST ABNORMAL 5 0.0002
801 ARRHYTHMIA 8 0.0002
802 PRODUCT DOSE OMISSION 11 0.0002
803 PRODUCT PRESCRIBING ERROR 4 0.0002
804 CATARACT 10 0.0002
805 BACK PAIN 39 0.0002
806 VISION BLURRED 23 0.0002
807 ACCIDENT 2 0.0002
808 CARDIO-RESPIRATORY ARREST 7 0.0002
809 GOUT 3 0.0002
810 BLOOD PRESSURE FLUCTUATION 4 0.0002
811 OEDEMA 9 0.0002
812 APHASIA 5 0.0002
813 PANIC ATTACK 6 0.0002
814 NEURALGIA 4 0.0002
815 SEIZURE 19 0.0002
816 END STAGE RENAL DISEASE 3 0.0002
817 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
818 ACCIDENTAL OVERDOSE 6 0.0002
819 EPILEPSY 5 0.0002
820 AGITATION 12 0.0002
821 INJECTION SITE URTICARIA 4 0.0002
822 NASOPHARYNGITIS 30 0.0002
823 HAEMORRHAGE 17 0.0002
824 BLOOD GLUCOSE ABNORMAL 3 0.0002
825 INFLUENZA 18 0.0002
826 THINKING ABNORMAL 3 0.0002
827 OXYGEN SATURATION DECREASED 9 0.0002
828 HYPONATRAEMIA 9 0.0002
829 ASTHENIA 60 0.0002
830 HYPOTENSION 32 0.0002
831 DYSPNOEA EXERTIONAL 6 0.0002
832 ABDOMINAL PAIN 37 0.0002
833 BLOOD URINE PRESENT 3 0.0002
834 NEUROPATHY PERIPHERAL 15 0.0002
835 FEELING JITTERY 3 0.0002
836 HYPOPHAGIA 4 0.0002
837 ACUTE RESPIRATORY FAILURE 3 0.0002
838 THERAPY NON-RESPONDER 7 0.0002
839 UNRESPONSIVE TO STIMULI 4 0.0002
840 EAR PAIN 3 0.0002
841 ABDOMINAL DISTENSION 16 0.0002
842 NERVOUSNESS 8 0.0002
843 SPEECH DISORDER 8 0.0002
844 CHOLELITHIASIS 5 0.0002
845 DISABILITY 3 0.0002
846 SPINAL FRACTURE 3 0.0001
847 GAIT INABILITY 5 0.0001
848 CYTOKINE RELEASE SYNDROME 3 0.0001
849 THROMBOSIS 12 0.0001
850 TYPE 2 DIABETES MELLITUS 5 0.0001
851 FALL 49 0.0001
852 NEUTROPENIA 20 0.0001
853 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
854 SOMNOLENCE 29 0.0001
855 MEDICATION ERROR 8 0.0001
856 PAIN IN JAW 4 0.0001
857 MUSCULAR WEAKNESS 16 0.0001
858 HYPOAESTHESIA 21 0.0001
859 ANGINA PECTORIS 4 0.0001
860 HYPOACUSIS 6 0.0001
861 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
862 ACCIDENTAL UNDERDOSE 2 0.0001
863 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
864 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
865 AMNESIA 9 0.0001
866 PRODUCT DISPENSING ERROR 3 0.0001
867 INJECTION SITE HAEMORRHAGE 11 0.0001
868 LIVER FUNCTION TEST ABNORMAL 4 0.0001
869 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
870 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
871 MUSCLE SPASMS 25 0.0001
872 CONFUSIONAL STATE 22 0.0001
873 BLOOD PRESSURE DECREASED 9 0.0001
874 PSYCHOTIC DISORDER 4 0.0001
875 URINARY INCONTINENCE 4 0.0001
876 INJECTION SITE PRURITUS 9 0.0001
877 GLOSSODYNIA 3 0.0001
878 ORAL PAIN 3 0.0001
879 RESPIRATORY DISORDER 4 0.0001
880 MUSCULOSKELETAL PAIN 7 0.0001
881 PANCREATITIS ACUTE 3 0.0001
882 DYSARTHRIA 5 0.0001
883 INTESTINAL OBSTRUCTION 5 0.0001
884 DEPRESSED MOOD 7 0.0001
885 DISCOMFORT 8 0.0001
886 GAIT DISTURBANCE 25 0.0001
887 INJECTION SITE PAIN 40 0.0001
888 SYNCOPE 13 0.0001
889 DISTURBANCE IN ATTENTION 7 0.0001
890 WEIGHT INCREASED 29 0.0001
891 LIMB DISCOMFORT 4 0.0001
892 FLUSHING 13 0.0001
893 INSOMNIA 34 0.0001
894 HEAD INJURY 4 0.0001
895 THERAPY INTERRUPTED 9 0.0001
896 HYPOTHYROIDISM 4 0.0001
897 HYPERHIDROSIS 16 0.0001
898 PRESYNCOPE 3 0.0001
899 LUNG DISORDER 6 0.0001
900 CONVULSION 7 0.0001
901 EYE DISORDER 4 0.0001
902 ABASIA 3 0.0001
903 DYSGEUSIA 9 0.0001
904 VISUAL IMPAIRMENT 15 0.0001
905 TREMOR 20 0.0001
906 AGEUSIA 3 0.0001
907 AGGRESSION 6 0.0001
908 COVID-19 21 0.0001
909 ROAD TRAFFIC ACCIDENT 5 0.0001
910 ABDOMINAL PAIN LOWER 3 0.0001
911 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
912 HAEMATEMESIS 3 0.0001
913 FLUID RETENTION 6 0.0001
914 MYALGIA 20 0.0001
915 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
916 BLOOD GLUCOSE INCREASED 22 0.0001
917 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
918 HAEMATOMA 3 0.0001
919 NIGHTMARE 4 0.0001
920 MENTAL DISORDER 5 0.0001
921 INJECTION SITE BRUISING 9 0.0001
922 CEREBROVASCULAR ACCIDENT 19 0.0001
923 FEAR 3 0.0001
924 ADVERSE DRUG REACTION 10 0.0001
925 CRYING 4 0.0001
926 HYPERGLYCAEMIA 4 0.0001
927 TREATMENT NONCOMPLIANCE 6 0.0001
928 MEMORY IMPAIRMENT 15 0.0001
929 RESPIRATORY ARREST 3 0.0001
930 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
931 ARTHROPATHY 6 0.0001
932 COGNITIVE DISORDER 5 0.0001
933 TOXICITY TO VARIOUS AGENTS 18 0.0001
934 RHEUMATOID ARTHRITIS 12 0.0001
935 COMA 5 0.0001
936 NEOPLASM MALIGNANT 7 0.0001
937 INJECTION SITE SWELLING 8 0.0001
938 BALANCE DISORDER 9 0.0001
939 DYSSTASIA 3 0.0001
940 PLASMA CELL MYELOMA 4 0.0001
941 ABNORMAL BEHAVIOUR 4 0.0001
942 DEVICE ISSUE 9 0.0001
943 SUICIDE ATTEMPT 6 0.0001
944 EXTRA DOSE ADMINISTERED 4 0.0001
945 EMOTIONAL DISORDER 3 0.0001
946 GYNAECOMASTIA 3 0.0001
947 EXPOSURE DURING PREGNANCY 6 0.0001
948 NERVOUS SYSTEM DISORDER 3 0.0001
949 BRADYCARDIA 5 0.0001
950 MOOD SWINGS 3 0.0001
951 MOVEMENT DISORDER 3 0.0001
952 LACTIC ACIDOSIS 3 0.0001
953 DEVICE DISLOCATION 4 0.0001
954 INCORRECT DOSE ADMINISTERED 21 0.0001
955 PRODUCT STORAGE ERROR 8 0.0001
956 VISUAL ACUITY REDUCED 3 0.0001
957 ANGER 3 0.0001
958 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
959 COMPLETED SUICIDE 7 0.0001
960 MYELOSUPPRESSION 3 0.0001
961 INJECTION SITE ERYTHEMA 10 0.0001
962 MUSCULOSKELETAL STIFFNESS 7 0.0001
963 HALLUCINATION 6 0.0001
964 HOSPITALISATION 12 0.0001
965 PANCREATITIS 4 0.0001
966 DRUG EFFECT DECREASED 4 0.0001
967 DEVICE BREAKAGE 3 0.0001
968 INFLUENZA LIKE ILLNESS 6 0.0001
969 DRUG DOSE OMISSION 12 0.0001
970 ABNORMAL DREAMS 2 0.0001
971 NO ADVERSE EVENT 13 0.0001
972 PARAESTHESIA 11 0.0001
973 PRODUCT SUBSTITUTION ISSUE 4 0.0001
974 INTENTIONAL PRODUCT MISUSE 6 0.0001
975 ACUTE MYOCARDIAL INFARCTION 2 0.0001
976 ILL-DEFINED DISORDER 4 0.0001
977 OVERDOSE 14 0.0001
978 BLOOD CHOLESTEROL INCREASED 3 0.0001
979 RENAL CANCER 3 0.0001
980 HYPOGLYCAEMIA 3 0.0001
981 DEVICE DIFFICULT TO USE 4 0.0001
982 MYOCARDIAL INFARCTION 10 0.0001
983 DEATH 49 0.0001
984 UNDERDOSE 4 0.0001
985 CARDIAC DISORDER 5 0.0001
986 INJECTION SITE REACTION 3 0.0000
987 DEVICE MALFUNCTION 3 0.0000
988 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
989 DRUG DOSE OMISSION BY DEVICE 3 0.0000
990 DRUG WITHDRAWAL SYNDROME 3 0.0000
991 BREAST CANCER 3 0.0000
992 DRUG DEPENDENCE 4 0.0000
993 ADVERSE EVENT 2 0.0000